Clinical trial
A Prospective, Randomized, Multicenter, Controlled Evaluation of the Efficacy and Safety of Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery
NCT00130715 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Multicenter, Controlled Evaluation of the Efficacy and Safety of Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 1998
- Completion date
- August 31, 2003
- Enrollment
- Not reported
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.
digestive system surgical procedures, intestinal obstruction